|M5873||Pexmetinib (ARRY-614)||Pexmetinib (ARRY-614) is a potent, orally bioavailable, dual p38 MAPK/Tie-2 inhibitor with IC50 of 4 nM/18 nM in a HEK-293 cell line. Phase 1.|
|M3751||Losmapimod||Losmapimod (GW856553) is a selective, potent, and orally active p38 MAPK inhibitor with pKi of 8.1 and 7.6 for p38α and p38β, respectively.|
|M3294||VX-745||VX-745 is a potent and selective inhibitor of p38α with IC50 of 10 nM, 22-fold greater selectivity versus p38β and no inhibition to p38γ.|
|M3048||TAK-715||TAK-715 is a p38 MAPK inhibitor for p38α with IC50 of 7.1 nM, 28-fold more selective for p38α over p38β, no inhibition to p38γ/δ, JNK1, ERK1, IKKβ, MEKK1 or TAK1.|
|M3011||Skepinone-L||Skepinone-L is a selective p38α-MAPK inhibitor with IC50 of 5 nM.|
|M2583||PD 169316||PD 169316 is a potent, cell-permeable and selective p38 MAP kinase inhibitor with IC50 = 89 nM.|
|M2318||LY2228820||LY2228820 is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM.|
|M2317||VX-702||VX-702 is a highly selective inhibitor of p38 MAPKα with IC50 of 4-20 nM.|
|M2136||PH-797804||PH-797804 is a highly selective and potent inhibitor of p38 MAP kinase with IC50 of 26 nM.|
|M2062||SB 202190||SB 202190 is a highly selective, potent and cell permeable inhibitor of p38 MAP kinase with IC50 values of 50 and 100 nM inhibiting p38α and p38β, respectively.|
|M1781||SB203580||SB203580 inhibits the IL-2-induced proliferation of primary human T cells, murine CT6 T cells, or BAF F7 B cells with an IC50 of 3-5 μM.|
|M1675||BIRB796||BIRB 796 (Doramapimod) is a protein kinase inhibitor of p38 MAPK with Kd of 100pM.|
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.